maltoheptaose has been researched along with chitosan in 2 studies
| Studies (maltoheptaose) | Trials (maltoheptaose) | Recent Studies (post-2010) (maltoheptaose) | Studies (chitosan) | Trials (chitosan) | Recent Studies (post-2010) (chitosan) |
|---|---|---|---|---|---|
| 114 | 0 | 39 | 27,648 | 232 | 21,257 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadokawa, J; Kaneko, Y; Matsuda, S | 1 |
| Chan, SC; Freeman, C; Ip, MS; Lam, DC; Mak, JC; Shum, DK | 1 |
2 other study(ies) available for maltoheptaose and chitosan
| Article | Year |
|---|---|
Chemoenzymatic syntheses of amylose-grafted chitin and chitosan.
Topics: Acetylation; Amylose; Chitin; Chitosan; Glucans; Green Chemistry Technology; Phosphorylases | 2007 |
S-maltoheptaose targets syndecan-bound effectors to reduce smoking-related neutrophilic inflammation.
Topics: Aged; alpha 1-Antitrypsin; Animals; Bronchi; Bronchoalveolar Lavage Fluid; Case-Control Studies; Chemokine CXCL1; Chitosan; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Glucans; Heparitin Sulfate; Humans; Inflammation; Inflammation Mediators; Leukocyte Elastase; Male; Middle Aged; Neutrophils; Peroxidase; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Sprague-Dawley; Smoking; Syndecan-1 | 2015 |